Phase II trial of neoadjuvant chemotherapy with bevacizumab plus FOLFOX6 [fluorouracil + folinic acid + oxaliplatin] chemotherapy for resectable case of liver metastasis
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2014
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- 13 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 15 Dec 2008 New trial record.